Editorial: Recent advancements in RNA-based and targeted therapeutics

Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine

The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Editorial: Liquid biopsy and new omics technologies in vascular malformations

The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers

The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions

Editorial: Lung adenocarcinoma: from genomics to immunotherapy

Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review

Editorial: Current trends and future perspectives about liquid biopsy

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis

Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors

Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation

MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy

A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome

Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients

PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis